Teva Pharma Industries Stock Price Prediction
| TEVA Stock | USD 16.69 0.43 2.51% |
Oversold Vs Overbought
41
Oversold | Overbought |
Quarterly Earnings Growth 0.4 | EPS Estimate Next Quarter 0.72 | EPS Estimate Current Year 2.4678 | EPS Estimate Next Year 2.7789 | Wall Street Target Price 22.3644 |
Using Teva Pharma hype-based prediction, you can estimate the value of Teva Pharma Industries from the perspective of Teva Pharma response to recently generated media hype and the effects of current headlines on its competitors.
Teva Pharma Industries Hype to Price Pattern
Investor biases related to Teva Pharma's public news can be used to forecast risks associated with an investment in Teva. The trend in average sentiment can be used to explain how an investor holding Teva can time the market purely based on public headlines and social activities around Teva Pharma Industries. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Teva Pharma's market sentiment to its price can help taders to make decisions based on the overall investors consensus about Teva Pharma.
The fear of missing out, i.e., FOMO, can cause potential investors in Teva Pharma to buy its stock at a price that has no basis in reality. In that case, they are not buying Teva because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Teva Pharma after-hype prediction price | USD 16.67 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Teva |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Teva Pharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Teva Pharma After-Hype Price Prediction Density Analysis
As far as predicting the price of Teva Pharma at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Teva Pharma or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Teva Pharma, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Teva Pharma Estimiated After-Hype Price Volatility
In the context of predicting Teva Pharma's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Teva Pharma's historical news coverage. Teva Pharma's after-hype downside and upside margins for the prediction period are 14.86 and 18.48, respectively. We have considered Teva Pharma's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Teva Pharma is not too volatile at this time. Analysis and calculation of next after-hype price of Teva Pharma Industries is based on 3 months time horizon.
Teva Pharma Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Teva Pharma is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Teva Pharma backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Teva Pharma, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.15 | 1.81 | 0.02 | 0.00 | 9 Events / Month | 12 Events / Month | In about 9 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
16.69 | 16.67 | 0.12 |
|
Teva Pharma Hype Timeline
Teva Pharma Industries is at this time traded for 16.69. The entity has historical hype elasticity of -0.02, and average elasticity to hype of competition of 0.0. Teva is anticipated to decline in value after the next headline, with the price expected to drop to 16.67. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -0.12%, whereas the daily expected return is at this time at -0.15%. The volatility of related hype on Teva Pharma is about 8791.43%, with the expected price after the next announcement by competition of 16.69. About 57.0% of the company shares are owned by institutional investors. The book value of Teva Pharma was at this time reported as 5.35. The company has Price/Earnings To Growth (PEG) ratio of 1.29. Teva Pharma Industries recorded a loss per share of 0.85. The entity last dividend was issued on the 27th of November 2017. The firm had 2:1 split on the 1st of July 2004. Given the investment horizon of 90 days the next anticipated press release will be in about 9 days. Check out Teva Pharma Basic Forecasting Models to cross-verify your projections.Teva Pharma Related Hype Analysis
Having access to credible news sources related to Teva Pharma's direct competition is more important than ever and may enhance your ability to predict Teva Pharma's future price movements. Getting to know how Teva Pharma's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Teva Pharma may potentially react to the hype associated with one of its peers.
Teva Pharma Additional Predictive Modules
Most predictive techniques to examine Teva price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Teva using various technical indicators. When you analyze Teva charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Teva Pharma Predictive Indicators
The successful prediction of Teva Pharma stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Teva Pharma Industries, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Teva Pharma based on analysis of Teva Pharma hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Teva Pharma's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Teva Pharma's related companies. | 2023 | 2024 (projected) | Dividend Yield | 0.004377 | 0.004158 | Price To Sales Ratio | 0.74 | 0.7 |
Story Coverage note for Teva Pharma
The number of cover stories for Teva Pharma depends on current market conditions and Teva Pharma's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Teva Pharma is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Teva Pharma's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Teva Pharma Short Properties
Teva Pharma's future price predictability will typically decrease when Teva Pharma's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Teva Pharma Industries often depends not only on the future outlook of the potential Teva Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Teva Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 1.1 B | |
| Cash And Short Term Investments | 3.2 B |
Complementary Tools for Teva Stock analysis
When running Teva Pharma's price analysis, check to measure Teva Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Teva Pharma is operating at the current time. Most of Teva Pharma's value examination focuses on studying past and present price action to predict the probability of Teva Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Teva Pharma's price. Additionally, you may evaluate how the addition of Teva Pharma to your portfolios can decrease your overall portfolio volatility.
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |